Respiratory Variations in the Diameter of the Inferior Vena Cava With Spontaneous Ventilation

November 17, 2025 updated by: Centre Hospitalier Universitaire de Nīmes

Respiratory Variations in the Diameter of the Inferior Vena Cava With Spontaneous Ventilation: A Physiological Study on Healthy Volunteers

The main objective of this study is to determine a threshold value of diaphragmatic excursion (ultrasound measures: expiration versus inspiration)that best predicts a 50% collapsibility of the inferior vena cava.

Study Overview

Detailed Description

Secondary objectives of this study are:

  • to determine a threshold value of diaphragmatic excursion (ultrasound measures: expiration versus inspiration)that best predicts a 40% collapsibility of the inferior vena cava (IVC).
  • to determine a threshold value of diaphragmatic excursion (ultrasound measures: expiration versus inspiration)that best predicts a 100% collapsibility of the IVC.
  • to determine the location of the cutting plane for the TM analysis of collapsibility of the IVC.
  • to evaluate the hemodynamic conditions of normal healthy volunteers.
  • to detect any abnormality of cardiac function.

Study Type

Interventional

Enrollment (Actual)

52

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Nîmes, France, 30029
        • CHU de Nimes - Hopital Universitaire Caremeau

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 50 years (Adult)

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • The volunteer must have given his/her informed and signed consent
  • The volunteer must be insured or beneficiary of a health insurance plan

Exclusion Criteria:

  • The volunteer is participating in another study
  • The volunteer is in an exclusion period determined by a previous study
  • The volunteer is under judicial protection, under tutorship or curatorship
  • The volunteer refuses to sign the consent
  • It is impossible to correctly inform the volunteer
  • The patient is pregnant, parturient, or breastfeeding
  • The volunteer has known heart disease like heart failure, cardiac arrhythmia
  • The volunteer takes cardiotropics
  • The volunteer has known lung disease: obstructive or restrictive respiratory failure
  • The volunteer has clinical signs of COPD (coughing with morning sputum in a smoking subject)
  • Any emergency situation

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Diagnostic
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Study population
Healthy subjects with spontaneous ventilation, 18 to 50 years of age.
The patient will have cardiac, abdominal and thoracic ultrasounds with controlled and monitored inspiratory effort. This gesture takes about 40 minutes.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Collapsibility score for the IVC diameter
Time Frame: Baseline (Day 0; cross-sectional study)

percentage = ((max-min)/average)*100%

Three variables are necessary to respond to the primary objective: (the collapsibility score for the IVC diameter; (2) whether or not this score is >= 50%; and (3) a measure of the diaphragmatic excursion.

Baseline (Day 0; cross-sectional study)
Collapsibility score for the IVC diameter >= 50% (presence/absence)
Time Frame: Baseline (Day 0; cross-sectional study)

percentage = ((max-min)/average)*100%

Three variables are necessary to respond to the primary objective: (the collapsibility score for the IVC diameter; (2) whether or not this score is >= 50%; and (3) a measure of the diaphragmatic excursion.

Baseline (Day 0; cross-sectional study)
Diaphragmatic excursion
Time Frame: Baseline (Day 0; cross-sectional study)

Maximum distance between the position of the diaphragmatic dome during inspiration versus expiration (cm)

Three variables are necessary to respond to the primary objective: (the collapsibility score for the IVC diameter; (2) whether or not this score is >= 50%; and (3) a measure of the diaphragmatic excursion.

Baseline (Day 0; cross-sectional study)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Collapsibility score for the IVC diameter >= 40% (presence/absence)
Time Frame: Baseline (Day 0; cross sectional study)
percentage = ((max-min)/average)*100%
Baseline (Day 0; cross sectional study)
Collapsibility score for the IVC diameter >= 60% (presence/absence)
Time Frame: Baseline (Day 0; cross sectional study)
percentage = ((max-min)/average)*100%
Baseline (Day 0; cross sectional study)
Mitral Doppler Wave E speed
Time Frame: Baseline (Day 0; cross sectional study)
cm/s
Baseline (Day 0; cross sectional study)
Mitral Doppler Wave A speed
Time Frame: Baseline (Day 0; cross sectional study)
cm/s
Baseline (Day 0; cross sectional study)
Tissue Doppler Wave E' speed
Time Frame: Baseline (Day 0; cross sectional study)
cm/s
Baseline (Day 0; cross sectional study)
Simpson: FEVG
Time Frame: Baseline (Day 0; cross sectional study)
%
Baseline (Day 0; cross sectional study)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Laurent Muller, MD, Centre Hospitalier Universitaire de Nīmes

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

September 1, 2012

Primary Completion (Actual)

September 17, 2012

Study Completion (Actual)

September 17, 2012

Study Registration Dates

First Submitted

July 17, 2012

First Submitted That Met QC Criteria

July 18, 2012

First Posted (Estimated)

July 19, 2012

Study Record Updates

Last Update Posted (Estimated)

November 19, 2025

Last Update Submitted That Met QC Criteria

November 17, 2025

Last Verified

March 1, 2015

More Information

Terms related to this study

Other Study ID Numbers

  • LOCAL/2012/LM-01
  • 2012-A00625-38 (Other Identifier: ANSM)

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Collapsibility of the Inferior Vena Cava

Clinical Trials on Ultrasounds with controlled breathing

Subscribe